Meet Samuel – Your Personal Investing Prophet
- Start a conversation with TipRanks’ trusted, data-backed investment intelligence
- Ask Samuel about stocks, your portfolio, or the market and get instant, personalized insights in seconds
ADICON Holdings Limited ( (HK:9860) ) has shared an announcement.
ADICON Holdings Limited has convened its 2026 annual general meeting for 27 May 2026 in Hong Kong, where shareholders will review the audited financial statements for the year ended 31 December 2025 and consider the re-election of four directors across executive, non-executive, and independent non-executive roles. Investors will also vote on directors’ and auditor’s remuneration, the re-appointment of Ernst & Young, and the renewal of general mandates allowing the board to repurchase up to 10% of the company’s shares and to issue new shares, moves that give management flexibility over capital structure and potential fundraising while signaling ongoing governance continuity.
The most recent analyst rating on (HK:9860) stock is a Buy with a HK$7.00 price target. To see the full list of analyst forecasts on ADICON Holdings Limited stock, see the HK:9860 Stock Forecast page.
More about ADICON Holdings Limited
ADICON Holdings Limited, incorporated in the Cayman Islands and listed in Hong Kong under stock code 9860, operates within the healthcare and diagnostics sector. The company provides medical testing and related diagnostic services, positioning itself to serve hospitals, clinics, and healthcare institutions in need of high-quality laboratory solutions.
Average Trading Volume: 1,247,479
Technical Sentiment Signal: Sell
Current Market Cap: HK$2.84B
See more data about 9860 stock on TipRanks’ Stock Analysis page.